Valued at $499
Included with a Subscription to Equio®
Want the full report?
Already a subscriber? Login
New Frontier Data’s latest report delivers an in-depth and comprehensive assessment of medical cannabis preferences and behaviors, consumer purchasing and consumption habits, and the potential impact on the prescription pharmaceutical industry.
Some Key Report Findings:
- Growth of Medical Cannabis: The medical cannabis market is projected to almost double to over $16 billion by 2025.
- Medical Market Intelligence: Nearly half of medical consumers (45%) identify smokable cannabis as their preferred product form while 24% prefer edibles and beverages, key insight for retailers and operators.
- Cannabis as an Alternative for Prescription Drugs: Leading prescription types replaced by medical cannabis include anticonvulsants (72%), glaucoma medication (71%), anti-migraine medication (65%), nausea suppressants (65%), and ADD/ADHD (62%).
